In 1901, the first Nobel Prize was awarded to recognize those who “have conferred the greatest benefit to humankind.” Often the work that goes into winning this prestigious award occurs over decades and uncovers the fundamental and “basic” nature of the universe. But after a scientific advancement has been recognized by the Nobel committee, will it ever deliver on its promise to confer a true benefit to humanity? During this panel, hear from scientists and company executives across different stages of drug development on how they are moving beyond just a laboratory experiment to bring “Nobel Prize-winning science” into human applications to shape the future of treatment for some of the most pressing health challenges today.